|
1
|
Wolfgang CL, Herman JM, Laheru DA, Klein
AP, Erdek MA, Fishman EK and Hruban RH: Recent progress in
pancreatic cancer. CA Cancer J Clin. 63:318–348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Klein AP: Identifying people at a high
risk of developing pancreatic cancer. Nat Rev Cancer. 13:66–74.
2013. View
Article : Google Scholar :
|
|
3
|
Gillen S, Schuster T, Meyer Zum
Buschenfelde C, Friess H and Kleeff J: Preoperative/neoadjuvant
therapy in pancreatic cancer: A systematic review and meta-analysis
of response and resection percentages. PLoS Med. 7:e10002672010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bapat AA, Hostetter G, Von Hoff DD and Han
H: Perineural invasion and associated pain in pancreatic cancer.
Nat Rev Cancer. 11:695–707. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hruban RH, Canto MI, Goggins M, Schulick R
and Klein AP: Update on familial pancreatic cancer. Adv Surg.
44:293–311. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Iodice S, Gandini S, Maisonneuve P and
Lowenfels AB: Tobacco and the risk of pancreatic cancer: A review
and meta-analysis. Langenbecks Arch Surg. 393:535–545. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Raimondi S, Lowenfels AB, Morselli-Labate
AM, Maisonneuve P and Pezzilli R: Pancreatic cancer in chronic
pancreatitis; aetiology, incidence, and early detection. Best Pract
Res Clin Gastroenterol. 24:349–358. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bosetti C, Rosato V, Li D, Silverman D,
Petersen GM, Bracci PM, Neale RE, Muscat J, Anderson K, Gallinger
S, et al: Diabetes, antidiabetic medications, and pancreatic cancer
risk: An analysis from the International Pancreatic Cancer
Case-Control Consortium. Ann Oncol. 25:2065–2072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wood LD and Hruban RH: Pathology and
molecular genetics of pancreatic neoplasms. Cancer J. 18:492–501.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hezel AF, Kimmelman AC, Stanger BZ,
Bardeesy N and Depinho RA: Genetics and biology of pancreatic
ductal adenocarcinoma. Genes Dev. 20:1218–1249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vincent A, Herman J, Schulick R, Hruban RH
and Goggins M: Pancreatic cancer. Lancet. 378:607–620. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Becker AE, Hernandez YG, Frucht H and
Lucas AL: Pancreatic ductal adenocarcinoma: Risk factors,
screening, and early detection. World J Gastroenterol.
20:11182–11198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Falzone L, Marconi A, Loreto C, Franco S,
Spandidos DA and Libra M: Occupational exposure to carcinogens:
Benzene, pesticides and fibers. Mol Med Rep. 14:4467–4474.
2016.Review. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Decker GA, Batheja MJ, Collins JM, et al:
Risk factors for pancreatic adenocarcinoma and prospects for
screening. Gastroenterol Hepatol (N Y). 6:246–254. 2010.
|
|
17
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang D, Chen Z, Xu H, He A, Liu Y and
Huang W: Long noncoding RNA CCAT2 as a novel biomaker of metastasis
and prognosis in human cancer: A meta-analysis. Oncotarget.
8:75664–75674. 2017.PubMed/NCBI
|
|
19
|
Aftab MN, Dinger ME and Perera RJ: The
role of microRNAs and long non-coding RNAs in the pathology,
diagnosis, and management of melanoma. Arch Biochem Biophys.
563:60–70. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Deng H, Wang JM, Li M, Tang R, Tang K, Su
Y, Hou Y and Zhang J: Long non-coding RNAs: New biomarkers for
prognosis and diagnosis of colon cancer. Tumour Biol.
39:1010428317706332. 2017. View Article : Google Scholar
|
|
21
|
Ding L, Ren J, Zhang D, Li Y, Huang X, Ji
J, Hu Q, Wang H, Ni Y and Hou Y: The TLR3 agonist inhibit drug
efflux and sequentially consolidates low-dose cisplatin-based
chemoimmunotherapy while reducing side effects. Mol Cancer Ther.
16:1068–1079. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang G, Lu X and Yuan L: LncRNA: A link
between RNA and cancer. Biochim Biophys Acta. 1839:1097–1109. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Deng K, Guo X, Wang H and Xia J: The
lncRNA-MYC regulatory network in cancer. Tumour Biol. 35:9497–9503.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ye N, Wang B, Quan ZF, et al: Functional
roles of long non-coding RNA in human breast cancer. Asian Pac J
Cancer Prev. 15:5993–5997. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Min F, Xinying LI, Wei J, Yun H, Jingdong
LI and Wang Z: A long non-coding RNA, TCSC3, as a tumor suppressor
and a target of miRNAs in thyroid cancer cells. Exp Ther Med.
5:1143–1146. 2013. View Article : Google Scholar
|
|
26
|
Kwok ZH and Tay Y: Long noncoding RNAs:
Lincs between human health and disease. Biochem Soc Trans.
45:805–812. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Peng WX, Koirala P and Mo YY:
LncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu Y, Zhang L, Wang Y, Li H, Ren X, Wei F,
Yu W, Wang X, Zhang L, Yu J, et al: Long noncoding RNA HOTAIR
involvement in cancer. Tumour Biol. 35:9531–9538. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wei W, Liu Y, Lu Y, Yang B and Tang L:
LncRNA XIST promotes pancreatic cancer proliferation through
miR-133a/EGFR. J Cell Biochem. 118:3349–3358. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gu L, Zhang J, Shi M, Zhan Q, Shen B and
Peng C: lncRNA MEG3 had anti-cancer effects to suppress pancreatic
cancer activity. Biomed Pharmacother. 89:1269–1276. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu BQ, Jiang Y, Zhu F, Sun DL and He XZ:
Long noncoding RNA VT1 promotes EMT and cell proliferation and
migration through downregulating p21 in pancreatic cancer cells.
Technol Cancer Res Treat. 16:819–827. 2017. View Article : Google Scholar
|
|
32
|
Chen S, Zhang JQ, Chen JZ, Chen H-X, Qiu
F-N, Yan M-L, Chen Y-L, Peng C-H, Tian Y-F and Wang Y-D: The over
expression of long non-coding RNA ANRIL promotes
epithelial-mesenchymal transition by activating the ATM-E2F1
signaling pathway in pancreatic cancer: An in vivo and in vitro
study. Int J Biol Macromol. 102:718–728. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang H, Guan Z, He K, Qian J, Cao J and
Teng L: LncRNA UCA1 in anti-cancer drug resistance. Oncotarget.
8:64638–64650. 2017.PubMed/NCBI
|
|
34
|
Liu B: BioSeq-Analysis: A platform for
DNA, RNA and protein sequence analysis based on machine learning
approaches. Brief Bioinform. Dec 19–2017.Epub ahead of print.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin Y, Qian F, Shen L, Chen F, Chen J and
Shen B: Computer-aided biomarker discovery for precision medicine:
Data resources, models and applications. Brief Bioinform. Nov
29–2017.Epub ahead of print. View Article : Google Scholar
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) methods. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
37
|
Han P and Chang CP: Long non-coding RNA
and chromatin remodeling. RNA Biol. 12:1094–1098. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Feng Y, Wu H, Xu Y, Zhang Z, Liu T, Lin X
and Feng X-H: Zinc finger protein 451 is a novel Smad corepressor
in transforming growth factor-beta signaling. J Biol Chem.
289:2072–2083. 2014. View Article : Google Scholar
|
|
40
|
Karvonen U, Jaaskelainen T, Rytinki M,
Kaikkonen S and Palvimo JJ: ZNF451 is a novel PML body- and
SUMO-associated transcriptional coregulator. J Mol Biol.
382:585–600. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Abascal F, Tress ML and Valencia A:
Alternative splicing and co-option of transposable elements: The
case of TMPO/LAP2alpha and ZNF451 in mammals. Bioinformatics.
31:2257–2261. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Eisenhardt N, Chaugule VK, Koidl S,
Droescher M, Dogan E, Rettich J, Sutinen P, Imanishi SY, Hofmann K,
Palvimo JJ, et al: A new vertebrate SUMO enzyme family reveals
insights into SUMO-chain assembly. Nat Struct Mol Biol. 22:959–967.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Bernardi R and Pandolfi PP: Structure,
dynamics and functions of promyelocytic leukaemia nuclear bodies.
Nat Rev Mol Cell Biol. 8:1006–1016. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Droescher M, Chaugule VK and Pichler A:
SUMO rules: Regulatory concepts and their implication in neurologic
functions. Neuromolecular Med. 15:639–660. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Engreitz JM, Sirokman K, McDonel P,
Shishkin AA, Surka C, Russell P, Grossman SR, Chow AY, Guttman M
and Lander ES: RNA-RNA interactions enable specific targeting of
noncoding RNAs to nascent Pre-mRNAs and chromatin sites. Cell.
159:188–199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Y, Cheng J, Xu C, Liu S, Jiang S, Xu
Q, Chen X, Zhuang H and Lu F: Quantitative methylation analysis
reveals gender and age differences in p16INK4a hypermethylation in
hepatitis B virus-related hepatocellular carcinoma. Liver Int.
32:420–428. 2012.
|
|
47
|
Zhang JC, Gao B, Yu ZT, Liu X-B, Lu J, Xie
F, Luo H-J and Li H-P: Promoter hypermethylation of p14 (ARF), RB,
and INK4 gene family in hepatocellular carcinoma with hepatitis B
virus infection. Tumour Biol. 35:2795–2802. 2014. View Article : Google Scholar
|
|
48
|
Fukai K, Yokosuka O, Imazeki F, Tada M,
Mikata R, Miyazaki M, Ochiai T and Saisho H: Methylation status of
p14ARF, p15INK4b, and p16INK4a genes in human hepatocellular
carcinoma. Liver Int. 25:1209–1216. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Shcherba M, Liang Y, Fernandes D,
Perez-Soler R and Cheng H: Cell cycle inhibitors for the treatment
of NSCLC. Expert Opin Pharmacother. 15:991–1004. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gong H, Wen H, Zhu X, Lian Y, Yang X, Qian
Z and Zhu J: High expression of long non-coding RNA ZEB1-AS1
promotes colorectal cancer cell proliferation partially by
suppressing p15 expression. Tumour Biol. 39:1010428317705336. 2017.
View Article : Google Scholar
|
|
51
|
Tian XP, Jin XH, Li M, Huang WJ, Xie D and
Zhang JX: The depletion of PinX1 involved in the tumorigenesis of
non-small cell lung cancer promotes cell proliferation via
p15/cyclin D1 pathway. Mol Cancer. 16:742017. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xiong Y, Hannon GJ, Zhang H, Casso D,
Kobayashi R and Beach D: p21 is a universal inhibitor of cyclin
kinases. Nature. 366:701–704. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ning P, Hu C, Li X, Zhou Y, Hu A, Zhang Y,
Gao L, Gong C, Guo K, Zhang X, et al: Classical swine fever virus
Shimen infection increases p53 signaling to promote cell cycle
arrest in porcine alveolar macrophages. Oncotarget. 8:55938–55949.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Jiang C, Liu G, Luckhardt T, Antony V,
Zhou Y, Carter AB, Thannickal VJ and Liu R-M: Serpine 1 induces
alveolar type II cell senescence through activating p53-p21-Rb
pathway in fibrotic lung disease. Aging Cell. 16:1114–1124. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Sato F, Kohsaka A, Takahashi K, Otao S,
Kitada Y, Iwasaki Y and Muragaki Y: Smad3 and Bmal1 regulate p21
and S100A4 expression in myocardial stromal fibroblasts via
TNF-alpha. Histochem Cell Biol. 148:617–624. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Ren J, Ding L, Xu Q, Shi G, Li X, Li X, Ji
J, Zhang D, Wang Y, Wang T, et al: LF-MF inhibits iron metabolism
and suppresses lung cancer through activation of
P53-miR-34a-E2F1/E2F3 pathway. Sci Rep. 7:7492017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kis A, Tatar TZ, Gall T, et al: Frequency
of genetic and epigenetic alterations of p14ARF and p16INK4A in
head and neck cancer in a Hungarian population. Pathology oncology
research. POR. 20:923–929. 2014.
|
|
58
|
Imamura T, Komatsu S, Ichikawa D, Miyamae
M, Okajima W, Ohashi T, Kiuchi J, Nishibeppu K, Konishi H, Shiozaki
A, et al: Depleted tumor suppressor miR-107 in plasma relates to
tumor progression and is a novel therapeutic target in pancreatic
cancer. Sci Rep. 7:57082017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Villarino N, Signaevskaia L, van Niekerk
J, Medal R, Kim H, Lahmy R, Scully K, Pinkerton A, Kim SW, Lowy A,
et al: A screen for inducers of bHLH activity identifies
pitavastatin as a regulator of p21, Rb phosphorylation and E2F
target gene expression in pancreatic cancer. Oncotarget.
8:53154–53167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Mohammad RM, Li Y, Muqbil I, Aboukameel A,
Senapedis W, Baloglu E, Landesman Y, Philip PA and Azmi AS:
Targeting Rho GTPase effector p21 activated kinase 4 (PAK4)
suppresses p-Bad-microRNA drug resistance axis leading to
inhibition of pancreatic ductal adenocarcinoma proliferation. Small
GTPases. Jun 22–2017.Epub ahead of print. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zubair H, Bhardwaj A, Ahmad A, Srivastava
SK, Khan MA, Patel GK, Singh S and Singh AP: Hydroxytyrosol induces
apoptosis and cell cycle arrest and suppresses multiple oncogenic
signaling pathways in prostate cancer cells. Nutr Cancer.
69:932–942. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
He L, Chen Y, Feng J, Sun W, Li S, Ou M
and Tang L: Cellular senescence regulated by SWI/SNF complex
subunits through p53/p21 and p16/pRB pathway. Int J Biochem Cell
Biol. 90:29–37. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ren J, Nie Y, Lv M, Shen S, Tang R, Xu Y,
Hou Y, Zhao S and Wang T: Estrogen upregulates MICA/B expression in
human non-small cell lung cancer through the regulation of ADAM17.
Cell Mol Immunol. 12:768–776. 2015. View Article : Google Scholar
|
|
64
|
Fischer M: Census and evaluation of p53
target genes. Oncogene. 36:3943–3956. 2017. View Article : Google Scholar : PubMed/NCBI
|
